Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Peter J Mogayzel"'
Autor:
Abhiram R Bhashyam, Peter J Mogayzel, Sharon McGrath-Morrow, Enid Neptune, Alla Malinina, James Fox, Beth L Laube
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e45312 (2012)
Previously, we have demonstrated that mucociliary clearance (MCC) is diminished within the first months after surgery in lung transplant patients and the explanation for the reduction in MCC is unknown. We hypothesized that chronic treatment with a c
Externí odkaz:
https://doaj.org/article/39c2c6238aab48d28b0b3d2d4dc55db4
Autor:
Shelby R. Sferra, Melanie K. Nies, Jena L. Miller, Alejandro V. Garcia, Erica I. Hodgman, Annalise B. Penikis, Abigail J. Engwall-Gill, Vera Joanna Burton, Jessica L. Rice, Peter J. Mogayzel, Ahmet A. Baschat, Shaun M. Kunisaki
Publikováno v:
Journal of Pediatric Surgery. 58:14-19
Although fetoscopic endoluminal tracheal occlusion (FETO) was recently shown to improve survival in a multicenter, randomized trial of severe congenital diaphragmatic hernia (CDH), morbidity outcomes remain essentially unknown. The purpose of this st
Publikováno v:
Journal of Cystic Fibrosis. 22:7-8
Autor:
Kathryn A. Carson, Garry R. Cutting, Joseph M. Collaco, Peter J. Mogayzel, Pamela L. Zeitlin, Melis A. Aksit, Vanessa L. Richardson, Beth L. Laube, Christopher M. Evans, Gail Sharpless
Publikováno v:
Pediatric Research. 91:612-620
Background This research characterized mucociliary clearance (MCC) in young children with cystic fibrosis (CF). Methods Fourteen children (5-7 years old) with CF underwent: two baseline MCC measurements (Visits 1 and 2); one MCC measurement approxima
Publikováno v:
J Pediatr Pharmacol Ther
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have revolutionized care for patients with cystic fibrosis (CF). The triple combination product elexacaftor/tezacaftor/ivacaftor is a highly effective CFTR modulator that is genera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8abc4c99e4ad1cbcf418e791db4ac521
https://europepmc.org/articles/PMC9268115/
https://europepmc.org/articles/PMC9268115/
Autor:
Beryl J. Rosenstein, Lindsay Jablonski, Peter J. Mogayzel, Carlton K. K. Lee, Shruti M. Paranjape, Alice Pan
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 25:623-628
OBJECTIVES Clinical practice guidelines for eradication of Pseudomonas aeruginosa (PA) in patients with cystic fibrosis (CF) have been established, but current studies have not assessed how these guidelines translate into clinical practice. This stud
Autor:
Kathleen B. Schwarz, Kathryn A. Carson, Alexandra Vasilescu, Paul Wasuwanich, Peter J. Mogayzel, Thammasin Ingviya, Wikrom Karnsakul
Publikováno v:
Journal of Cystic Fibrosis. 19:546-552
Background & Aims A practical, inexpensive, and non-invasive biomarker of liver fibrosis is needed as a reliable screening test for cystic fibrosis-associated liver disease (CFLD). Studies have shown the utility of AST to Platelet Ratio Index (APRI),
Autor:
Gail Sharpless, Christopher M. Evans, Peter J. Mogayzel, Kathryn A. Carson, Vanessa L. Richardson, Pamela L. Zeitlin, Beth L. Laube
Publikováno v:
Pediatr Pulmonol
Objectives (a) To quantify changes in mucociliary clearance (MCC) over time in children with cystic fibrosis (CF) and the relationship between MCC and rate of infection with Pseudomonas aeruginosa (PA); (b) to determine the impact of MCC on the evolu
Autor:
John P. Clancy, Agathe Ceppe, Jihong Wu, Timothy E. Corcoran, Pradeep Bhambhvani, Peter J. Mogayzel, Beth L. Laube, Scott D. Sagel, Felix Ratjen, Joseph M. Pilewski, Steven M. Rowe, William D. Bennett, Scott H. Donaldson
Publikováno v:
J Cyst Fibros
CFTR function is required for normal mucociliary clearance (MCC) and cough-assisted clearance (CC). Lumacaftor-ivacaftor is approved for use in people with cystic fibrosis (CF) carrying two copies of F508del-CFTR. In this observational study performe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0921b8b1d58af1181fd7ea53dafe02e
https://europepmc.org/articles/PMC8630086/
https://europepmc.org/articles/PMC8630086/
Autor:
Lindsay, Jablonski, Carlton K K, Lee, Beryl J, Rosenstein, Peter J, Mogayzel, Shruti, Paranjape, Alice, Pan
Publikováno v:
J Pediatr Pharmacol Ther
OBJECTIVES: Clinical practice guidelines for eradication of Pseudomonas aeruginosa (PA) in patients with cystic fibrosis (CF) have been established, but current studies have not assessed how these guidelines translate into clinical practice. This stu